Prospective studies focusing on tumor immunity and FBXO5 expression may be beneficial in providing a definite answer, thereby facilitating the development of an immunotherapy approach targeting FBXO5 for tumor in the future. This evidence concerns the gene FBXO5 and neoplasm.